Tissue Procurement For Hematolymphoid Conditions TISSUE, BLOOD, AND BODY FLUID SAMPLE COLLECTION

What's the purpose of this trial?

RATIONALE: Collecting and storing samples of tissue, blood, and body fluid from patients with cancer to study in the laboratory may help the study of cancer in the future. PURPOSE: This research study is collecting and storing blood and tissue samples from patients being evaluated for hematologic cancer.

This trial is currently open and accepting patients.

What will happen during the trial?


  • Provide source of patient tissue, blood, and body fluid samples for ongoing diagnostic, prognostic, or immune-monitoring studies.
  • Support and enhance translational, clinical and basic research for Lineberger Comprehensive Cancer Center (LCCC) members (and non-members who have an LCCC member as sponsor and collaborator) with IRB-approved studies.
  • Maintain responsible and appropriate policies and procedures that ensure good patient care and responsible conduct of research.
  • Address medical and legal issues, and protect participant and patient privacy and confidentiality.
  • Provide a responsible and uniform mechanism for the integrated coordination of the hemato-pathologist and surgeon or hematology/oncology staff, researcher, and protocol office to obtain appropriate specimens for researchers.
  • Support young investigators to obtain pilot data for grant funding.

OUTLINE: Patients undergo tissue, blood, and body fluid collection during diagnostic or routine procedures for future correlative studies. Tissue samples may include, but are not limited to, lymph node or non-nodal biopsies, bone marrow biopsy and/or aspirate, blood and serum, and buccal swabs for germline DNA analysis.

You may be able to join this trial if you:

The following criteria is a partial list of reasons why patients may be eligible to participate in this clinical trial. Further evaluation with a medical professional is required.


* Diagnosis of abnormal hematopoietic/lymphoid cancer, including any of the following:

* Acute myeloid leukemia
* Acute lymphoblastic leukemia
* Chronic myelogenous leukemia
* Chronic lymphoid leukemia
* Non-Hodgkin lymphoma
* Hodgkin lymphoma
* Myelodysplastic syndromes
* Myeloproliferative disorders
* Multiple myeloma
* Waldenstrom macroglobulinemia
* Aplastic anemia
* Any other diseases that generate abnormalities in either number, function, or both of any cell type of hematolymphoid lineage
* Patients who are being evaluated at the hematology/oncology clinics of the University of North Carolina Hospitals, at the stem cell transplant clinic, or in the hospital


* Not specified


* Not specified

Additional Trial Information

Observational Trial

Enrollment: 15,000 patients (estimated)

View More

Trial Locations

All Trial Locations

View all clinical trial locations sorted by state.

North Carolina

UNC Lineberger Comprehensive Cancer Center University of North Carolina

Chapel Hill, NC

Open and Accepting
Interested in this trial?
  • Call us today 😀 keyboard_arrow_right

    We know how difficult and confusing this process can be. If you are interested in this clinical trial or have questions, you can call us at any time. You can also send us a direct message with questions.

    (888) 828-2206
  • If you are interested in keeping an eye on this trial, you can add it to your list of favorite trials. We'll send you alerts when this trial is updated.

  • Talk to your doctor keyboard_arrow_right

    You can print an overview of this trial to take in to your next appointment. Your doctor can help you understand if this trial may be right for you.

Still need help? Send us a message